Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

(CRL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
340.24(c) 343.02(c) 345.91(c) 354.78(c) 352.09(c) Last
358 648 293 519 297 988 390 863 301 914 Volume
+1.01% +0.82% +0.84% +2.56% -0.76% Change
More quotes
Financials (USD)
Sales 2021 3 521 M - -
Net income 2021 329 M - -
Net Debt 2021 1 590 M - -
P/E ratio 2021 54,8x
Yield 2021 -
Sales 2022 3 928 M - -
Net income 2022 480 M - -
Net Debt 2022 1 352 M - -
P/E ratio 2022 37,8x
Yield 2022 -
Capitalization 17 694 M 17 694 M -
EV / Sales 2021 5,48x
EV / Sales 2022 4,85x
Nbr of Employees 18 400
Free-Float 98,2%
More Financials
Company
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in... 
More about the company
Ratings of Charles River Laboratories International, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
06/07CHARLES RIVER LABORATORIES INTERNATI : Signs Long-Term Solar Contract With Duke ..
MT
06/07CHARLES RIVER LABORATORIES INTERNATI : Announces Long-Term Solar Contract for No..
PU
06/02INSIDER TRENDS : Insider at Charles River Labs International Tax Sale Continues ..
MT
05/28CHARLES RIVER LABORATORIES INTERNATI : UBS Adjusts Price Target on Charles River..
MT
05/28CHARLES RIVER LABORATORIES INTERNATI : JPMorgan Adjusts Price Target on Charles ..
MT
05/28CHARLES RIVER LABORATORIES INTERNATI : Credit Suisse Raises Charles River Labora..
MT
05/28CHARLES RIVER LABORATORIES INTERNATI : to Participate in June Investor Conferenc..
BU
05/28CHARLES RIVER LABORATORIES INTERNATI : Citigroup Adjusts Price Target on Charles..
MT
05/27CHARLES RIVER LABORATORIES INTERNATI : 2021 Meeting with Management Presentation
PU
05/26CHARLES RIVER LABORATORIES INTERNATI : to Host Virtual Investor Day
BU
05/25CHARLES RIVER LABORATORIES INTERNATI : Truist Securities Adjusts Price Target on..
MT
05/19CHARLES RIVER LABORATORIES INTERNATI : Bionity - Charles River Laboratories to A..
AQ
05/18CHARLES RIVER LABORATORIES INTERNATI : Form 8-K)
PU
05/18CHARLES RIVER LABORATORIES INTERNATI : Change in Directors or Principal Officers..
AQ
05/17CHARLES RIVER LABORATORIES INTERNATI : to Acquire Vigene Biosciences for $292.5 ..
MT
More news
News in other languages on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
05/11STOCK MARKET PARIS : Trop vite, trop loin, trop fort ?
05/11EN DIRECT DES MARCHESá : Alstom, Crédit Agricole, Carbios, Pierre & Vacances, Lu..
04/01IRW-PRESS : Gold Terra Resource Corp.: Gold Terra meldet Einreichung eines techn..
02/26DGAP-NEWS : DLA Piper berät die Darlehensgeber bei der Refinanzierung des Warnow..
02/19LINEDATA SERVICES : Interview de Anvaraly Jiva, PDG de Linedata
More news
Analyst Recommendations on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
More recommendations
Stock Trading Strategies
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - 2020
The underlying trend is to the upside
BUY
More Stock Trading Analysis
Chart CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Duration : Period :
Charles River Laboratories International, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Average target price 362,73 $
Last Close Price 352,09 $
Spread / Highest target 16,4%
Spread / Average Target 3,02%
Spread / Lowest Target -51,7%
EPS Revisions
Managers and Directors
NameTitle
James C. Foster Chairman, President & Chief Executive Officer
David Ross Smith Chief Financial Officer & Executive Vice President
Arthur C. Hubbs Chief Information Officer & Senior Vice President
Matthew L. Daniel Secretary & Chief Compliance Officer
Barbara j. Patterson Senior VP-Regulatory Affairs & Compliance
Sector and Competitors
1st jan.Capitalization (M$)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.40.91%17 694
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
IQVIA HOLDINGS INC.35.87%46 658
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416